Fundraising FoxAsklepios BioPharmaceutical
Durham, US · Delaware corporation · 1 known investors
Find your way into Asklepios BioPharmaceutical
Sign up to see every warm intro you have to Asklepios BioPharmaceutical
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Asklepios BioPharmaceutical team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
SM
Sheila MikhailCEO, Treasurer and Secretary
RS
Richard SamulskiPresident and Chief Science Officer
KW
Katherine WoodNamed on SEC filing
FC
Fred CohenNamed on SEC filing
JG
Javier GarciaNamed on SEC filing
JS
John SchillingNamed on SEC filing
WH
William HawkinsNamed on SEC filing
JS
Jon SalvesonNamed on SEC filing
TF
Timothy FergusonAssistant Secretary
Investors · 1
Vida VenturesreportedLos Angeles
How we know: funding news · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$199.7M disclosed across 1 round · 2019
▶$199.7MraisedMay 2019 · 33 investors · BiotechnologyRule 506(b)
▶$199.7MraisedMay 2019 · 33 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Katherine WoodDirector
- Fred CohenDirector
- Javier GarciaDirector
- John SchillingDirector
- Timothy FergusonExecutive Officer
- Sheila MikhailExecutive Officer, Director
- Richard SamulskiExecutive Officer, Director
- William HawkinsDirector
- Jon SalvesonDirector
- Offering amount
- $199.7M
- Amount sold
- $199.7M
- Minimum investment
- $101.3K
- Proceeds to insiders
- $190.5K
- First sale
- Apr 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who founded Asklepios BioPharmaceutical?
- Asklepios BioPharmaceutical was founded by Sheila Mikhail, Richard Samulski.
- Who are Asklepios BioPharmaceutical's investors?
- Asklepios BioPharmaceutical's investors include Vida Ventures.
- How much funding has Asklepios BioPharmaceutical raised?
- Asklepios BioPharmaceutical has disclosed $199.7M raised across 1 round.
- Where is Asklepios BioPharmaceutical headquartered?
- Asklepios BioPharmaceutical is headquartered in Durham, US.